Jason Aryeh
Director/Board Member at ORCHESTRA BIOMED HOLDINGS, INC.
Net worth: 6 M $ as of 2024-04-29
Profile
Jason M.
Aryeh is the founder of JALAA Equities LP (founded in 1997) and Rio Grande Renewables LLC (founded in 2009).
He held the title of Managing General Partner at JALAA Equities LP and Chairman at Rio Grande Renewables LLC.
Currently, Mr. Aryeh holds the position of Independent Director at Ligand Pharmaceuticals, Inc. since 2006, Director at Orchestra BioMed, Inc. since 2018, Director at Cytovia Therapeutics, Inc. since 2021, Independent Director at Anebulo Pharmaceuticals, Inc. since 2021, Independent Non-Executive Director at Orchestra Biomed Holdings, Inc. since 2023, and Director at Cytovia Holdings, Inc. and Omicron Delta Epsilon.
In the past, Mr. Aryeh served as Vice Chairman at Immunomedics, Inc. in 2017, Chairman at Novelion Therapeutics, Inc. from 2012 to 2018, Director at QLT, Inc. in 2012, Independent Director at Nabi Biopharmaceuticals from 2011 to 2012, Director at CorMatrix Cardiovascular, Inc. from 2010 to 2017, Independent Director at Myrexis, Inc. from 2011 to 2013, Director at Cystic Fibrosis Foundation Therapeutics, Inc. from 2011 to 2018, and Independent Director at Old API Wind-down Ltd.
from 2016 to 2017.
Mr. Aryeh obtained his undergraduate degree from Colgate University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-29 | 81,853 ( 0.46% ) | 6 M $ | 2024-04-29 | |
| 2024-04-25 | 62,984 ( 0.18% ) | 279 649 $ | 2024-04-29 | |
| 2023-09-29 | 0 ( -.--% ) | - $ | 2024-04-29 |
Jason Aryeh active positions
| Companies | Position | Start |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Director/Board Member | 2006-09-26 |
| ANEBULO PHARMACEUTICALS, INC. | Director/Board Member | 2021-02-28 |
| ORCHESTRA BIOMED HOLDINGS, INC. | Director/Board Member | 2023-01-25 |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Director/Board Member | 2021-05-12 |
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Director/Board Member | 2018-10-31 |
Omicron Delta Epsilon
 Omicron Delta Epsilon Miscellaneous Commercial ServicesCommercial Services Omicron Delta Epsilon operates as an academic honor society. The company was founded in 1963 and is headquartered in Fairhope, AL. | Corporate Officer/Principal | - |
| Cytovia Holdings, Inc. | Director/Board Member | - |
Former positions of Jason Aryeh
| Companies | Position | End |
|---|---|---|
| NOVELION THERAPEUTICS INC. | Chairman | 2018-07-31 |
Cystic Fibrosis Foundation Therapeutics, Inc.
 Cystic Fibrosis Foundation Therapeutics, Inc. BiotechnologyHealth Technology Part of Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Inc. engages in drug discovery and development. The company is based in Bethesda, MD. | Director/Board Member | 2018-01-31 |
| ░░░ ░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Jason Aryeh
| Colgate University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| MYREXIS, INC. | Finance |
| LIGAND PHARMACEUTICALS INCORPORATED | Health Technology |
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| ORCHESTRA BIOMED HOLDINGS, INC. | Health Technology |
| Private companies | 13 |
|---|---|
JALAA Equities LP
 JALAA Equities LP Investment ManagersFinance JALAA Equities LP is an independent hedge fund manager headquartered in Greenwich, Connecticut. The firm was founded by Jason Aryeh in 1997 and manages assets of high net worth clients. | Finance |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |
Omicron Delta Epsilon
Omicron Delta Epsilon Miscellaneous Commercial ServicesCommercial Services Omicron Delta Epsilon operates as an academic honor society. The company was founded in 1963 and is headquartered in Fairhope, AL. | Commercial Services |
Nabi Biopharmaceuticals
 Nabi Biopharmaceuticals BiotechnologyHealth Technology Nabi Biopharmaceuticals develops and manufactures biopharmaceutical products. It focuses on the development of vaccines addressing unmet medical needs, including gram-positive bacterial infections and nicotine addiction. The Nicotine Addiction area develops NicVAX, which is an innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse based on patented technology. Nabi Biopharmaceuticals was founded in 1969 and is headquartered in Rockville, MD. | Health Technology |
CorMatrix Cardiovascular, Inc.
 CorMatrix Cardiovascular, Inc. Medical SpecialtiesHealth Technology CorMatrix Cardiovascular, Inc. develops and markets commercial medical devices. It offers CorMatrix CanGaroo, Vascular Repair, Pericardial Repair & Reconstruction, Tyke, and Cardiac Tissue Repair. The company was founded by David B. Camp and Robert G. Matheny in 2001 and is headquartered in Roswell, GA. | Health Technology |
Cystic Fibrosis Foundation Therapeutics, Inc.
Cystic Fibrosis Foundation Therapeutics, Inc. BiotechnologyHealth Technology Part of Cystic Fibrosis Foundation, Cystic Fibrosis Foundation Therapeutics, Inc. engages in drug discovery and development. The company is based in Bethesda, MD. | Health Technology |
Novelion Therapeutics, Inc.
 Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada. | Health Technology |
Old API Wind-down Ltd.
 Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Aralez Pharmaceuticals Inc. engages in the development, acquisition, and commercialization of cardiovascular, pain, and other product therapies. It operates through the following geographical segments: United States and Canada. The company is founded on December 2, 2015, and is headquartered in Mississauga, Canada. | Health Technology |
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Orchestra BioMed, Inc. develops therapies for cardiovascular diseases. The firm offers BackBeat CNT and Virtue SEB. The company was founded in 2017 and is headquartered in New Hope, PA. | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Cytovia Therapeutics, Inc. engages in transformational immunotherapies for cancer and severe acute infectious diseases. Its products include Multi-Specific NK Engager Antibodies and iPSC CAR NK cells. The company was founded by Daniel Teper, Gilles Seydoux, and Massimo Radaelli and is headquartered in New York, NY. | Health Technology |
| Rio Grande Renewables LLC | |
| Cytovia Holdings, Inc. |
- Stock Market
- Insiders
- Jason Aryeh
